Agilent Techs., Inc.

Agilent Technologies, Inc. is a global public company headquartered in Santa Clara, California, that provides instruments, software, services, and consumables for laboratories. Founded in 1999 as a spin-off from Hewlett-Packard, it is traded on the NYSE under the ticker symbol "A". As of June 2026, Agilent has a market capitalization of approximately $36-37 billion USD and employs around 18,100 people worldwide. The company reported revenues of $6.95 billion in fiscal year 2025.

Agilent's products and services cater to the life sciences, diagnostics, and applied chemical markets. Its offerings include instruments like gas and liquid chromatographs, mass spectrometers, and cell analysis systems, alongside a range of software, bioreagents, and consumables. Key business segments include Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab, which provides extensive services and laboratory automation solutions.

Agilent Technologies, Inc. exhibits an active, two-way patent litigation posture, engaging in litigation both as a plaintiff and a defendant. The company has been involved in two tracked cases, one as a plaintiff and one as a defendant. Both cases were filed in federal district courts: the Delaware District Court and the Northern District of California.

The company's patent litigation is exemplified by two closely related cases filed in October 2021: Agilent Techs., Inc. v. Synthego Corp. in the Delaware District Court, where Agilent was the plaintiff, and Synthego Corp. v. Agilent Techs., Inc. in the Northern District of California, where Agilent was the defendant. These simultaneous filings suggest direct disputes with other operating companies, rather than consistent assertion against diverse targets typical of a non-practicing entity.